Attitude toward COVID-19 vaccination: A cross-sectional study on healthcare professionals.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 250, doi. 10.4103/ijp.ijp_173_21
- By:
- Publication type:
- Article
Works matching IS 02537613 AND DT 2021 AND VI 53 AND IP 3
Results: 14
1
2
Written informed consent to virtual e-consent in clinical research: Changing necessity during COVID times.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 248, doi. 10.4103/ijp.ijp_331_21
- By:
- Publication type:
- Article
3
Potential effects of itolizumab treatment on plasma interleukin-6 levels in patients with severe COVID-19.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 246, doi. 10.4103/ijp.IJP_33_21
- By:
- Publication type:
- Article
4
Candidiasis in patients treated with interleukin-17 inhibitors.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 244, doi. 10.4103/ijp.ijp_1178_20
- By:
- Publication type:
- Article
5
Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 236, doi. 10.4103/ijp.ijp_382_21
- By:
- Publication type:
- Article
6
A case report on azathioprine-induced euprolactinemic galactorrhea.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 234, doi. 10.4103/ijp.ijp_159_18
- By:
- Publication type:
- Article
7
The effects of empagliflozin on cardiometabolic risk factors in patients with type 2 diabetes: A short-term observational study.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 229, doi. 10.4103/ijp.IJP_669_18
- By:
- Publication type:
- Article
8
Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 226, doi. 10.4103/ijp.IJP_615_20
- By:
- Publication type:
- Article
9
Copper-lowering agents as an adjuvant in chemotherapy.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 221, doi. 10.4103/ijp.IJP_68_20
- By:
- Publication type:
- Article
10
Evaluation of vanillin as a probe drug for aldehyde oxidase and phenotyping for its activity in a Western Indian Cohort.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 213, doi. 10.4103/ijp.IJP_463_18
- By:
- Publication type:
- Article
11
Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 207, doi. 10.4103/ijp.ijp_1013_20
- By:
- Publication type:
- Article
12
Nephroprotective effects of ethanolic root extract of Azima tetracantha lam in adenine-induced chronic kidney failure in Wistar rats.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 198, doi. 10.4103/ijp.IJP_552_19
- By:
- Publication type:
- Article
13
Retrospective pharmacovigilance analysis of nonsteroidal anti-inflammatory drugs-induced chronic kidney disease.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 192, doi. 10.4103/ijp.IJP_704_20
- By:
- Publication type:
- Article
14
Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 187, doi. 10.4103/ijp.ijp_430_21
- By:
- Publication type:
- Article